4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-042663
CEO, CFO, Director acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-11-20 | Grant or award | +10,000 | $0.51 | $5,100 | 57,781 | D |
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-11-21 | Grant or award · Restricted Stock Units | +38,000 | 38,000 | D | ||
| Finley John David CEO, CFO, Director | 2023-11-21 | Grant or award · Common Stock Options | +45,000 | 45,000 | D | ||
Loading xslF345X05/ownership.xml…